Profil
Elena Traistaru is currently the Chief Financial Officer at Emerald Health Bioceuticals, Inc. and the Corporate Controller at Emerald Health Usa, Inc. She previously worked as the Controller at Enigma Diagnostics Ltd. from 2010 to 2017, the Chief Financial Officer at Skye Bioscience, Inc. in 2020, and the President & Chief Financial Officer at Et Accounting Consulting from 2017 to 2018.
Ms. Traistaru obtained her undergraduate degree from Bucharest Academy of Economic Studies.
Aktive Positionen von Elena Traistaru
| Unternehmen | Position | Beginn |
|---|---|---|
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Provides research and development of phytocannabinoids and nutritional supplements for support of human endocannabinoid health | Finanzdirektor/CFO | 01.10.2019 |
Emerald Health Usa, Inc. | Comptroller/Controller/Auditor | 01.11.2018 |
Ehemalige bekannte Positionen von Elena Traistaru
| Unternehmen | Position | Ende |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Finanzdirektor/CFO | 25.09.2020 |
Et Accounting Consulting | Vorstandsvorsitzender | 01.10.2018 |
Enigma Diagnostics Ltd.
Enigma Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings | Comptroller/Controller/Auditor | 01.02.2017 |
Ausbildung von Elena Traistaru
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Enigma Diagnostics Ltd.
Enigma Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings | Health Technology |
Bucharest Academy of Economic Studies
Bucharest Academy of Economic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Provides research and development of phytocannabinoids and nutritional supplements for support of human endocannabinoid health | Health Technology |
Emerald Health Usa, Inc. | |
Et Accounting Consulting |
















